Cargando…
Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
Autores principales: | Ulhaq, Zulvikar Syambani, Soraya, Gita Vita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351402/ https://www.ncbi.nlm.nih.gov/pubmed/32950258 http://dx.doi.org/10.1016/j.medcli.2020.07.002 |
Ejemplares similares
-
Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020) -
The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020) -
Interleukin-6 as a potential biomarker of COVID-19 progression
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020) -
Interleukin-6 levels in children developing SARS-CoV-2 infection
por: Soraya, Gita Vita, et al.
Publicado: (2020) -
An urgent call to identify the probable cause of severe acute hepatitis outbreak in children
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2022)